Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2015

Dec 8, 2015

30016_dirs_2015-12-08_157ab15d-d919-4c11-9982-e1aadb57aa8f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2015-12-05

Reporting Person: POWERS JOHNNY D (Executive Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-12-05 Common Stock M 962 $0.00 Acquired 26441 Direct
2015-12-05 Common Stock F 480 $70.40 Disposed 25961 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-12-05 Restricted Stock Unit $ M 962 Disposed Common Stock (962) Direct

Footnotes

F1: The number of securities reported reflects a 2-for-1 stock split in the form of a 100% stock dividend on IDEXX Laboratories, Inc. common stock paid on June 15, 2015 (the "Stock Split") and includes 82 shares (without giving effect to the Stock Split) and 79 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on June 30, 2015 and September 30, 2015, respectively

F2: Reflects the closing price of Issuer's common stock on the NASDAQ market on December 4, 2015.

F3: Represents restricted stock units previously granted on December 5, 2013 that have vested. Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date of the date of grant. The number of restricted stock units reported was adjusted to reflect the Stock Split.

F4: Not applicable.